News

Deal Announcements

Hemoshear Garners Third Venture Capital Round

Thursday, May 8, 2014 5:16:00 AM PDT | VentureDeal
   Charlottesville, VA  --  Biotechnology company Hemoshear has secured $8.7 million in Series C financing, according to a company statement.

Hemoshear has developed technology that provides cell-based human surrogate models of organ systems.

Investors in the round were not disclosed.

Hemoshear said that it will relocate its operations and accelerate development of its human disease modeling systems.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1